Baxa introduces ExactaMix 1200

Published: 10-Nov-2010

Allows automation of micro and macro ingredient compounding


Baxa Corporation, a US-based provider of medical devices and systems that automate pharmacy operations, has introduced the ExactaMix 1200 Automated Compounding Device (ACD) for hospital pharmacies requiring an automated approach to compounding large-volume parenteral doses.

The company says the entry-level 12-port compounder extends the Baxa ExactaMix product line and brings delivery precision and safe handling to pharmacies that want the compounding safety and efficiency that automation offers, but do not require the capabilities of the ExactaMix 2400.

The ExactaMix products automatically compound sterile doses, minimising the risk of measurement errors, wrong drug selection, touch contamination and patient infection in the preparation of solutions for TPN, cardioplegia, dialysis and epidural delivery.

Capable of volumes as low as 0.2mL, the new ExactaMix 1200 delivers both micro and macro ingredients.

Baxa compounding technology delivers final bag accuracies within +/- 4% with barcode ingredient verification, and pumps a typical 3-litre nutrition bag in approximately 3.5min.

‘The ExactaMix 1200 dispels the myth that only large healthcare facilities and hospitals can take advantage of the safety and efficiency of proven, cutting-edge automated compounding technology,’ said Laura Zoerner, senior product manager at Baxa Corporation.

You may also like